InSphero cooperates with numerous partners from different fields to advance compound de-risking and to support the growth and success of the company. View our Technical Protocols, Application Notes and Posters to learn how InSphero is partnering with some of industry's leading technology providers to help you make the most of your 3D cell culture.
Rely on our excellent partners building on our 3D cell culture technology
A leading global supplier of liquid handling robots with proven 3D experience. Hamilton’s systems are in use at InSphero for large-scale production of microtissues.
INTEGRA Biosciences AG
Offers a range of automated hand-held and bench-top pipetting instruments ideally suited for production and assaying of 3D microtissues in InSphero’s GravityPLUS Platform.
Luxcel Biosciences Ltd., Ireland
Luxcel Biosciences develop and provide phosphorescence and fluorescence based sensors for use with InSphero 3D microtissues.
Perkin Elmer Corp.
Working closely with InSphero on integrating InSphero GravityTRAP assay plates for 3D microtissues into their Opera and Operetta High-Content Analysis systems for functional imaging.
Promega Corp., USA
A leading supplier of assay kits, who works closely with InSphero since 2010 to validate and to optimize assays for use with 3D microtissue spheroids.
Biognosys AG, Switzerland
Biognosys is the leading proteomics company offering services and products for highly multiplexed protein quantification. Founded in 2008 as spin-off from the lab of proteomics pioneer Ruedi Aebersold at ETH Zurich, Biognosys is dedicated to transform life science with superior technology and software.
Protea Biosciences Group, Inc., USA
Protea is a leader in mass spectrometry imaging for preclinical R&D, biomarker discovery and the life sciences. In collaboration with InSphero, Protea is applying its mass spectrometry imaging technologies and bioanalytics capabilities to 3D InSight™ microtissues, toward the development of novel solutions for the companies' respective customers.
SCREEN Holdings Co., Ltd., Japan
SCREEN Holdings Co., Ltd. (formerly Dainippon Screen Mfg. Co., Ltd.) operates in total 47 group companies both domestically and internationally, including the world's top share products: semiconductor cleaning equipment, CTP devices, and FPD's Coater/Developers. Based on three core technologies: surface processing, direct imaging, and image processing, SCREEN is proactively expanding business in four new fields (energy, inspection and measurement, life sciences, and printed electronics). Established in 1943.
Seahorse Bioscience, Inc., USA
Seahorse Bioscience develops metabolic analyzers and assay kits that measure real-time cell metabolism in live cells. The XFe96 Spheroid Microplate enables functional, metabolic measurements of 3D in vitro spheroids via innovative microplate geometry that ensures correct positioning of the spheroid to deliver reproducible measurements of cellular respiration and glycolysis.
SIRION BIOTECH GmbH, Germany
Develops genetically modified 3D microtissue solutions using InSphero’s GravityPLUS system.
Solentim Ltd., UK
The fully automated bench-top system CellMetric for measuring visual, non-invasive cell content will soon support automated assessment of 3D microtissue size in the GravityTRAP plate.
Sophistolab AG, Switzerland
InSphero’s partner for histological analysis of 3D microtissues with a strong expertise in immuno-staining and microtissue handling.
Tecan’s fluorescent plate readers, especially the Infinite 200 PRO series which provides unique features for cell-based studies, are an excellent choice for assays performed in InSphero’s GravityTRAP plates. Tecan and InSphero collaborate to provide joint customers with technical guidance.
ALPCO offers a wide range of testing solutions, providing scientists and healthcare professionals with vital insights for advancing research and quality of care.
InSphero’s Academic Collaboration Partners
Dr. Arno Ammann, Medizinische Universität Innsbruck, Austria
Laboratory for Molecular Cell Biology
Prof. Dr. Michael J. Atkinson, Helmholtz Zentrum München, Germany
Institute of Radiation Biology
Dr. Laurent Barbe, CSEM SA, Switzerland
Prof. Olivier Devuyst, University of Zurich, Switzerland
Institute of Physiology, Center for Integrative Human Physiology (ZIHP), Mechanisms of Inherited Kidney Disorders Group
Prof. Elmar Heinzle, Dr. Fozia Noor, Saarland University, Germany
Applied Biochemistry, Biochemical Engineering
Prof. Jan Hengstler, Leibniz Research Centre for Working Environment and Human Factors, Germany
Prof. Dr. Andreas Hierlemann, ETH Zurich, Switzerland
Bio Engineering Laboratory Basel
PD. Dr. Patrick Hunziker, University Hospital Basel, Switzerland
Research group NANOMEDICINE, Medical Intensive Care Unit, National Centre of Competence in Nanoscale Science
Prof. Wilhelm Krek, ETH Zürich, Switzerland
Institute of Cell Biology
Prof. Magnus Ingelman-Sundberg
Karolinska Institute, Department of Physiology and Pharmacology
Prof. Dr. Stig Linder, Karolinska University Hospital, Sweden
Karolinska Institute, Cancercentrum
Anne-Marie Mes-Masson, Hôpital Notre-Dame, Canada
Research Centre CHUM & Cancer Institute of Montréal
Dr. Lars Keld Nielsen, The University of Queensland, Australia
Australian Institute for Bioengineering and Nanotechnology (AIBN)
Prof. Alex Odermatt, University of Basel, Switzerland
Prof. Dr. Liliane Schoofs, KULeuven, Belgium
Animal Physiology and Neurobiology Section
Prof. Dr. Ernst Stelzer, Goethe University Frankfurt, Germany
Institute of Cell Biology and Neuroscience
Dr. Christian Zuppinger, University of Berne, Switzerland
Department of Clinical Research Cardiovascular Research Group
Prof. Dr. Alain G. Zeimet, Innsbruck Medical University, Austria
Department of Obstetrics and Gynecology
Our other partners and memberships